Low-molecular-weight heparin as a bridging anticoagulant early after mechanical heart valve replacement.

Abstract

BACKGROUND After mechanical heart valve replacement (MHVR), long-term use of unfractionated heparin is sometimes required because vitamin K antagonists (VKA) are temporarily contraindicated or because the time to reach the target international normalized ratio is long. The aim of this study was to investigate the feasibility of low-molecular-weight heparin… (More)

Topics

2 Figures and Tables

Cite this paper

@article{Meurin2006LowmolecularweightHA, title={Low-molecular-weight heparin as a bridging anticoagulant early after mechanical heart valve replacement.}, author={Philippe Meurin and Jean Yves Tabet and H{\'e}l{\`e}ne Weber and Nathalie Renaud and Ahmed Ben Driss}, journal={Circulation}, year={2006}, volume={113 4}, pages={564-9} }